Rennie Soft Chews 800mg chewable tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Calcium carbonate

Available from:

Bayer Plc

ATC code:

A02AC01

INN (International Name):

Calcium carbonate

Dosage:

800mg

Pharmaceutical form:

Chewable tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 01010201; GTIN: 0000050506378 5010605298035

Patient Information leaflet

_SOFT CHEWS 800MG _
_CHEWABLE TABLETS _
_ _
_ _
_ _
Bayer cross
_ _
Calcium carbonate
READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT
INFORMATION
FOR YOU.
This medicine is available without prescription. However, you still
need to take
Rennie Soft Chews tablets carefully to get the best results from them.
Keep this
leaflet, you may need to read it again. Ask your pharmacist if you
need more
information or advice. You must contact a doctor if your symptoms
worsen or do
not improve. If you have any unusual effects after taking Rennie Soft
Chews, tell
your doctor or pharmacist.
IN THIS LEAFLET
1. What are Rennie Soft Chews and what are they used for?
2. Before you take Rennie Soft Chews
3. How to take Rennie Soft Chews
4. Possible side effects
5. How to store Rennie Soft Chews
6. Further information
1. WHAT ARE RENNIE SOFT CHEWS AND WHAT ARE THEY USED FOR?
RENNIE SOFT CHEWS are soft and chewy antacid tablets, with a smooth
freshmint
taste, which quickly and effectively relieve the discomfort of
indigestion,
heartburn, acid indigestion, dyspepsia, nervous indigestion,
flatulence, upset
stomach, indigestion during pregnancy and biliousness.
2. BEFORE YOU TAKE RENNIE SOFT CHEWS
DO NOT TAKE RENNIE SOFT CHEWS:
• If you have severe kidney disease.
• If you have high calcium in the urine or kidney stones.
• If you have high calcium or low phosphate levels in the blood.
• If you are allergic (hypersensitive) to any of the ingredients
(_listed in Section 6. _
_Further Information_).
SPECIAL PRECAUTIONS:
Do not exceed the stated dose.
1.3.1
1
Rennie Soft Chews should not be used for a prolonged period without
consulting
a doctor.
Please consult your doctor or pharmacist if you have any kidney
problems.
This product contains sucrose and glucose. If you have been told by
your doctor
that you have an intolerance to some sugars, contact your doctor
before taking
this medicinal product.
If symptoms persist consult your doctor.
TAKING OTHER MEDICINES:
• Please tell your doctor or pharmacist if you are tak

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Rennie Soft Chews 800mg chewable tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Calcium Carbonate
800.0 mg
Also contains sucrose and glucose
For full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Chewable Tablets.
Square green soft chewable tablets
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
For the relief of indigestion, heartburn, nervous indigestion,
hyperacidity,
flatulence, upset stomach, dyspepsia, biliousness, overindulgence in
food and
drink, indigestion during pregnancy.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology:
Tablets to be taken orally, sucked or chewed.
Adults and children over 12 years:
One or two tablets to be sucked or chewed as a single dose, preferably
to be taken one
hour after meals and before going to bed but also in between in case
of heartburn or
gastric pain. A maximum daily dose of 8 g calcium carbonate
corresponding to 10
tablets a day must not be exceeded.
Elderly:
No special dosage regimen is required, but care should be taken to
observe the
contraindications and warnings.
Children under 12 years: Not recommended.
As with all antacids, if symptoms persist despite 14 days of
continuous therapy,
diagnostic measures are strongly recommended in order to rule out a
more serious
disease.
4.3
CONTRAINDICATIONS
Rennie should not be administered to patients with:

Nephrocalcinosis

Severe renal function impairment (creatinine clearance below 30
ml/min)
Hypophosphatemia

Hypersensitivity to the active ingredients or any of the excipients,
refer to
section 6.1.

Hypercalcaemia
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
•
Prolonged use should be avoided.
•
Do not exceed the stated dose and if symptoms persist consult your
doctor.
•
Caution should generally be exercised in the case of patients with
impaired renal function. If Rennie is used in such patients, plasma
calcium and phosphate levels should be regularly monitored.
•
Long term uses at high doses can result in undesirable effec